Physician profile
David Daniel Dearing
NPI 1851583173
$4,876.59
in general payments reported to CMS, 2019-2025
17 companies · $96.07 in 2025
The $96.07 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $553 · 2021: $37.09 · 2022: $3,689 · 2023: $57.35 · 2024: $224 · 2025: $96.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $377.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $3,722.85 | 2019-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Endologix LLC | $289.20 | 2020-2024 | Alto Abdominal Stent Graft System |
| Cook Medical LLC | $288.80 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $91.32 | 2020-2022 | |
| Abbvie INC. | $75.34 | 2023-2025 | Alloderm |
| Ethicon US, LLC | $68.98 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $67.01 | 2019-2022 | |
| Abbott Laboratories | $58.29 | 2020-2021 | |
| Inspiremd LTD | $53.27 | 2025 | Cguard Prime Carotid Stent System |
| Bolton Medical INC | $28.02 | 2024 | Treo Abdominal Stent-Graft System |
| Medtronic, INC. | $26.94 | 2024 | Endurant Iis |
| Angiodynamics, INC. | $26.79 | 2019 | |
| Boston Scientific Corporation | $22.95 | 2025 | Enroute Transcarotid Neuroprotection System |
| Allergan, INC. | $19.88 | 2019 | |
| Smith+Nephew, INC. | $19.59 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $14.68 | 2019 | |
| Cvrx, INC. | $2.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dearing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.